NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer … – National Institutes of Health (press release)
National Institutes of Health (press release) |
NIH partners with 11 leading biopharmaceutical companies to accelerate the development of new cancer …
National Institutes of Health (press release) PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers of disease and treatment response — to advance new immunotherapy treatments that harness the immune system to attack cancer. To accelerate new cancer treatments, NIH will team up with pharma on immunotherapy research NIH, drug companies launch Cancer Moonshot partnership |
